TABLE 6B – QUALITY OF CARE INDICATORS
| Section F – Adult Weight Screening and Follow-up | ||||
| Adult Weight Screening and Follow-up | Total patients aged 18 and over ( a ) | Number Charts sampled or EHR total ( b ) | Number of patients with BMI charted and follow-up plan documented as appropriate ( c ) | |
| 13 | MEASURE: Patients aged 18 and over with (1)_BMI charted and (2) follow-up plan documented if patients are overweight or underweight | 
			 | 
			 | 
			 | 
| 
			 | ||||
| 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | 
| 
			 | ||||
| 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | 
| Section G – Tobacco use Screening and Cessation | ||||
| Tobacco Use Screening and Cessation | Total patients aged 18 and over ( a ) | Number Charts sampled or EHR total ( b ) | Number of patients assessed and intervened with as appropriate ( c ) | |
| 14a | MEASURE: Patients screened for tobacco use and who received cessation counseling intervention or medication if identified as a tobacco user one or more times in the measurement year or prior year | 
			 | 
			 | 
			 | 
| Section H – Asthma Pharmacological Therapy | ||||
| Asthma Treatment Plan | Total Patients aged 5 - 40 with persistent asthma ( a ) | Number Charts Sampled or EHR Total ( b ) | Number of Patients with Acceptable Plan ( c ) | |
| 16 | MEASURE: Patients aged 5 through 40 diagnosed with persistent asthma who have an acceptable pharmacological treatment plan | 
			 | 
			 | 
			 | 
| 
			 | ||||
| 
			 | 
			 | 
			 | 
			 | |
| 
			 | 
			 | 
			 | 
			 | 
			 | 
| Section J – Ischemic Vascular Disease (IVD): Aspirin or Antithrombotic Therapy | ||||
| Aspirin or Other Antithrombotic Therapy | Total Patients 18 And Over With IVD Diagnosis or AMI, CABG, or PTCA Procedure ( a ) | Charts Sampled or EHR Total ( b ) | Number of Patients With Aspirin or Other Antithrombotic Therapy ( c ) | |
| 18 | MEASURE: Patients aged 18 and older with a diagnosis of IVD or AMI,CABG, or PTCA procedure with aspirin or another antithrombotic therapy | 
			 | 
			 | 
			 | 
| Section K – Colorectal Cancer Screening | ||||
| Colorectal Cancer Screening | Total Patients 51 through 74 Years of age ( a ) | Charts Sampled or EHR Total ( b ) | Number of Patients With Appropriate Screening For Colorectal Cancer ( c ) | |
| 19 | MEASURE: Patients age 51 through 74 years of age during measurement year (on or prior to 31 December) with appropriate screening for colorectal cancer | 
			 | 
			 | 
			 | 
| Section L – Newly Identified HIV Cases with Timely Followup | ||||
| New HIV cases with timely followup | Patients first diagnosed with HIV ( a ) | Charts Sampled or EHR Total ( b ) | Patients first diagnosed seen within 90 days of diagnosis ( c ) | |
| 20 | Measure: Patients whose first ever HIV diagnosis was made by health center staff between October 1 and September 30 and who were seen for followup within 90 days of that first ever diagnosis. (See manual.) | 
			 | 
			 | 
			 | 
| Section M – Patients Screened for Depression and followed up if appropriate | ||||
| Patients screened for depression and followed up as appropriate | Total patients aged 12 and over ( a ) | Number Charts sampled or EHR total ( b ) | Number of patients screened and follow-up plan documented as appropriate ( c ) | |
| 21 | Measure: Patients aged 12 and over who were (1) screened for depression with a standardized tool and (2) had a follow-up plan documented if patients were considered depressed | 
			 | 
			 | 
			 | 
| File Type | application/msword | 
| File Title | Reporting Period: January 1, 2014 through December 31, 2014 | 
| Author | Art Stickgold | 
| Last Modified By | Windows User | 
| File Modified | 2013-10-25 | 
| File Created | 2013-10-25 |